Sentrimed, Inc.
Biotechnology company · Mullica Hill, New Jersey, United States
Sentrimed, Inc. is a biotechnology company headquartered in Mullica Hill, New Jersey, United States. Its earliest recorded incorporation is in 2023. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $604,066 in total, most recently in 2022. It has reported private securities offerings to the US SEC, most recently $250,000 sold in a notice filed in 2026.
Sentrimed at a glance
What does Sentrimed do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $604,066 in total (2022). NIH funding came from the National Cancer Institute.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $250,000 sold (2026).
Frequently asked questions about Sentrimed
Where is Sentrimed headquartered?
Sentrimed, Inc. is headquartered in Mullica Hill, New Jersey, United States.
What does Sentrimed do?
Sentrimed, Inc. is a biotechnology company.
When was Sentrimed founded?
The earliest incorporation on record for Sentrimed, Inc. is in 2023, according to public company registers.
Similar companies
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
- Vaxcyte, Inc.San Carlos, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences